Nov 27 (Reuters) - Canada's health regulator has approved Novo Nordisk's (NOVOb.CO), opens new tab weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback